Nutrition For Your Life Nutrition For Your Life
Home Page
BAZI Enery Drink
BAZI IS NOT DEAD
Company Info
Antioxidants
Quality Control
FAQs
Shipping
About Us
Contact Us
Privacy Policy
Links
Site Map

BAZI XELR8 Company Information

This info comes from yahoo finance http://biz.yahoo.com/prnews/080326/clw036.html?.v=101

Press Release

Source: XELR8 Holdings, Inc.

XELR8 Holdings Announces Fiscal 2007 Financial Results
Wednesday March 26, 9:00 am ET - Company Reports Record 2007 Revenue of $4.9 Million, an Increase of 126% - - Removal of the Going Concern Qualification by its Independent Registered Public Accountants - - Management to Host Conference Call Today at 4:15 p.m. ET -

DENVER, March 26 /PRNewswire-FirstCall/ -- XELR8 Holdings, Inc. (Amex: BZI - News), a provider of functional foods, beverages and nutritional supplements, today announced its financial results for the twelve months ended December 31, 2007.

Financial and operational highlights for Fiscal 2007: -- Revenues increased 126% over prior year period -- Gross profit margin was 72%, up 800 basis points from 64% in 2006

-- Bazi(TM) represented 83% of revenues in 2007, major growth component -- Working capital of $2.1 million as of December 31, 2007

Total revenue for the fiscal year ended December 31, 2007 was $4.9 million, a 126% increase compared to total revenue of $2.1 million for the fiscal year ended December 31, 2006. Gross profit grew to $3.5 million for the fiscal 2007, up 153% from $1.4 million in the prior year period. Net loss for the year ended December 31, 2007, decreased 31% to $3.2 million, or $0.23 per share, compared to a loss of $4.7 million, or $0.48 per share, in the prior year.

The Company's balance sheet continues to remain strong. As of December 31, 2007, cash and cash equivalents were $2.25 million, excluding the proceeds from the February 2008 financing. Total shareholders' equity at the end of fiscal 2007 was $2.22 million and the Company remains debt free. As a result of the improved operating performance and the additional financing, the Company's Independent Registered Public Accountants have removed the going concern qualification from their report.

"I am pleased with XELR8's performance in fiscal 2007," said John Pougnet, XELR8 CEO. "Fiscal 2007 was a pivotal year for XELR8, especially with the launch of our lead product Bazi, in January 2007, which has become a dominant part of our revenues as well as our anchor for future growth."

Mr. Pougnet continued, "During fiscal 2007 we built an excellent foundation for marketing Bazi, ending the year with 8,416 participants nationwide. We have begun leveraging our distributor base in fiscal 2008 through various means that we believe will not only assist them in building their current clientele, but also enhance our network by finding more distributors to broaden our reach. In addition to our recent distributor convention in Las Vegas, which was a resounding success, we have begun to offer new incentives and bonus features as well as incorporate regional "Go Diamond" events, to be hosted in six major cities nationwide in the coming weeks. It is events like these that enable us to keep in touch with our distributors and not only help in their growth, but also learn and grow from their success stories that we can then share network-wide."

"We are focused on attaining profitability and are getting closer to that goal daily. Fortunately, the Company is well capitalized and can undertake expenditures that will not only contribute ultimately to profitability but also strengthen our distribution network leading to broader acceptance of our products and, in particular, Bazi," concluded Mr. Pougnet.

There will be a conference call today at 4:15 p.m. ET with the investment community, featuring John Pougnet, Chief Executive Officer of XELR8 Holdings, Inc. Interested parties may participate in the call by dialing 877-407-8293; international callers dial 201-689-8349. In addition, a replay of the conference call will be available approximately two hours after the call has ended. The replay can be accessed at: www.xelr8tools.com/Media/ConfCall032608.mp3 and will be archived for 30 days.

About XELR8 Holdings, Inc.

XELR8 Holdings, Inc. is a provider of nutritional foods and beverages designed to help enhance physical health and overall performance. XELR8 has developed a comprehensive line of nutritional supplements and functional foods designed in systems that are easy to take, simple to understand, and conveniently fit within a lifestyle. These include the Company's Eat/Drink/Snack System; Peak Performance System; and its newest market entry, Bazi(TM), a powerful, concentrated, antioxidant (Vitamins A, C & E) nutritional drink packed with eight different super fruits and berries, including the Chinese jujube plus 12 vitamins and 68 minerals, providing all the daily vitamins and minerals you need in a single, convenient, one-ounce shot.

XELR8's commitment to quality, science and research has earned the Company a loyal following of over 350 world-class athletes and an elite list of endorsers, such as 3-time World Series Champion Curt Schilling, five-time Cy Young Award Winner Randy Johnson; Super Bowl Champions Mike Alstott and Lawyer Milloy; professional football star Cadillac Williams; Olympians Briana Scurry and Caroline Lalive; Stanley Cup Winner Blake Sloan; and PGA Tour Professional Tom Pernice, Jr. XELR8 products are only available through independent distributors located throughout the nation.

Forward-looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including prospects for XELR8's distribution network. Actual results may differ from those discussed in such forward-looking statements. These forward-looking statements include risks and uncertainties that include the Company's ability to attract and retain distributors; changes in demand for the Company's products; changes in the level of operating expenses; changes in general economic conditions that impact consumer behavior and spending; product supply; the availability, amount, and cost of capital for the Company; and the Company's use of such capital. More information about factors that potentially could affect the Company's financial results is included in the Company's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-KSB for the year ended December 31, 2006 and all subsequent filings. Certain statements in this release regarding the Company's agreements are in accordance with the guidelines established by the Federal Trade Commission for endorsements in advertising.

Custom Search


Custom Search
This is not a corporate website. This site is owned and operated by  D & D Enterprises, an independent distributor of XELR8
This is not a corporate website. This site is owned and operated by D & D Enterprises, an independent distributor of XELR8.
We accept VISA, MC, AMEX, DISCOVER
Order securely online with any major credit card 24 hours a day 7 days a week 365 days a year
Note: All prices in US Dollars

Disclaimer
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Success with XELR8 results only from successful sales and down line building efforts, which require hard work, diligence, and leadership. Your success will depend upon how effectively you exercise these qualities. No claims are made or implied that in any way guarantee earnings by participation or enrollment as an XELR8 distributor. D&D Enterprises is an authorized XELR8 distributor.

Copyright © D & D Enterprises
1728 Cannon, Casper, Wy 82601
Mon - Fri 9:00 to 5:00 (MST)
denterprise@juno.com

Your order is SSL Secured! Always look for the "S" directly behind the http in the Address bar and the yellow lock on the bottom right corner


Order securely on-line 24 hours a day
7 days a week, 365 days a year